Filgrastim Completed Phase 2 Trials for Neutropenias / Thrombocytopenias / Anemias / Leukemias Supportive Care

IndicationsStatusPurposePhase
CompletedSupportive Care2
clinicaltrials.gov IdentifierTitleDrugs
NCT00004215Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia